Want to write a case report? RFN has you covered with a list of journals to choose from
Have a Nephrology Question? There Might Be A #Tweetorial For That!
Conferences, Courses, & Grants
FOAMed
Interventional Nephrology Series
Focus on Point-of-Care Ultrasound in Nephrology (POCUN) Series
Landmark Nephrology Series
Kidney Biopsy of the Month Series
Urine Sediment of the Month Series
Donor-derived cell-free DNA in Kidney Transplantation: The Next Frontier
Paresh R. Jadav, MD (jadav_md)Dept of Nephrology, Columbia University Medical Center, New York, NY Introduction Kidney allograft monitoring is dependent upon non-specific markers like creatinine, estimated glomerular filtration rate (eGFR), and proteinuria. Kidney biopsy remains the gold standard…
The Kidney Transplant Recipient Evaluation: A Primer on Basics and Assessment
Orhan EfeNephrology FellowBrigham Womens Hospital/Massachusetts General Hospital ProgramHarvard Medical School Background and Basics The goal of transplant evaluation is to identify suitable candidates who would benefit from transplantation. To accomplish this goal, a multidisciplinary team is required. This…
Preemptive Kidney Transplantation: Past, Present and Future
Introduction Kidney transplantation (KT) has been proven to be the optimal form of kidney replacement therapy (KRT) with resultant lower morbidity and mortality rates, and better quality of life. Why do preemptive kidney transplant recipients have a survival…
A Case of Primary Hyperoxaluria Type 1 & Combined Liver-Kidney Transplant
Hyperoxaluria can cause a spectrum of disease ranging from urinary stone disease (USD), chronic kidney disease (CKD), end stage kidney disease (ESKD) to systemic deposition of oxalate leading to end organ damage. It can be broadly divided into…
A Guide to Immunosuppression in Transplantation
During my first year of fellowship, I always found myself interested in the pharmacology of the multiple immunosuppression meds, however, finding concise yet thorough sources of information on them was nearly impossible. Luckily, we have a very fellow…